ScribeAmerica was established in 2003, while the concept of medical scribe utilization in the industry has been anecdotally reported since the 1970's, ScribeAmerica transformed this cottage operation into a national industry. In 2006, we were the first company to demonstrate that the synergy of the Scribe/MD/EMR model could overcome productivity losses experienced by unassisted physicians using EMR. In 2008, we were the first scribe company providing services on both coasts and the only scribe company present at ACEP, AAOS, and SHM. We credit our success to our generous profit-sharing business model whereby the actual Project Leaders who manage our client's programs are rewarded. By enfranchising our employee base, we ensure limited attrition among management and attract the best talent in the industry to run your program.

VPExam provides optimal longitudinal Heart Failure management with continuity of care from home the clinic to the ER to the ICU and back.

The mission is to decentralize access to Cardiovascular Care. Our platform facilitates a highly effective and efficient transitional care program for cardiac patients, initially focusing on heart failure. The VPExam platform assists in the early detection of cardiac abnormalities and decompensation by proactively managing patient care: the physician improves patient quality of care, reducing re-hospitalizations and delivering more efficient, cost-effective care to the patient. The VPExam platform overcomes the barriers of traditional telemedicine, allowing comprehensive physical examinations utilizing Augmented Reality (AR) guidance.

Speke is agnostic the the EHR. While recommended, we can support Speke without EHR integrations which promotes fast and small pilots to prove provider buy-in and overall adoption.

• We partner with Cardiologists to improve the lives of their patients by overcoming barriers of traditional telemedicine using optimized VPExam virtual care workflows.

• VPExam is the first cardiology focused value-based care company to use technology and continuous care management to deliver peer reviewed publications documenting improved health with reduced readmissions and mortality of cardiovascular patients while significantly reducing cost of care.

o Enables better care for sicker and more complex HF patients.

o Cost effective and portable care to reach high-risk underserved populations in nursing facilities, hospitals, offices, and into the home.

o Customized to each physician with actionable and timely results.

• VPExam Virtual Care for Heart Failure Optimizing Transitions (VPExam QI)

o Revealed 84% moderate clinical modification in care, 40.1% reduction in 30-day rehospitalization, 56.3% reduction in 30-day mortality, 100% compliance with

follow up, and 0% technical errors.

• Growing industry recognition for multiple publications and awards including the Heart Rhythm Society (HRS) Breakthrough Innovation in Cardiovascular Digital Health and Digital Health Hub Foundation 2023 Best in Class Next Generation Telemedicine awards.